Product 2 definition

Product 2 means PRODUCT LABELED AND PACKAGED by FIOCRUZ at the FACILITIES from NAKED VIALS supplied to FIOCRUZ by PROTALIX.
Product 2 means any product approved for radiolabeling with technetium 99m containing Lymphoseek® (or any alternative or replacement name), with the chemical name tilmanocept, in a 62.5µg single-dose volume packaging configuration and any other single-dose volume packaging configuration, and any Improvements thereto or thereof.
Product 2 means Bastnasite suitable for polishing applications or further refinement into other Rare Earth products stored by Molycorp at the Facility.

Examples of Product 2 in a sentence

  • Notwithstanding the foregoing, ITW shall have no liability or duty to defend and indemnify Purchaser against any Claim relating to: (1) the use of any part or Product, (2) the combination of any part or Product with any other part or product not supplied by ITW, or (3) any part or Product or process that is designed or specified by Purchaser.

  • Any such person or party making a claim will be treated as though they are insured separately under this Policy Product 2.

  • This Limited Warranty does not include any cost of labor or other costs related to (1) un- installing Covered Product; (2) re-installing a repaired or replacement product, or (3) the removal, installation or troubleshooting of the Covered Owner's electrical systems.

  • This Limited Warranty does not include any cost of labor related to (1) un-installing Covered Product; (2) re-installing a repaired or replacement product, or (3) the removal, installation or troubleshooting of the Covered Owner's electrical systems.

  • Any claim indemnified under Section 1 of Policy Product 2 – Public Liability.


More Definitions of Product 2

Product 2 means [***].
Product 2 shall have the meanings set forth in the License Agreement.
Product 2 means a Product containing at least Compound 2.
Product 2. The annual License Fee shall be the greater of $10,000 (the “Minimum Annual Fee”) or one basis point (.0001) of the average daily net assets of the Product computed quarterly. For the first year of this Agreement, the maximum fee payable to S&P shall be $75,000; for the second year of this Agreement the maximum fee payable to S&P shall be $87,500; for the third year of this Agreement, the maximum fee shall be $100,000; for each year thereafter during the term of this Agreement, the maximum fee payable to S&P shall be $100,000 plus the amount of increase (if any) in the Consumer Price Index (“CPI”) for Urban Consumers, All Items, as issued by the Bureau of Labor Statistics, U.S. Department of Labor, over the prior twelve month period. The Minimum Annual Fee shall be payable on the Commencement Date and each one-year anniversary thereof. Amounts in excess of the Minimum Annual Fee shall be paid to S&P within thirty (30) days after the close of each calendar quarter in which they are incurred; each such payment shall be accompanied by a statement setting forth the basis for its calculation. With respect to each additional Master Fund covered by this Agreement pursuant to a separate written agreement between S&P Barclays Global Investors Mutual Fund Master/Feeder 500 and Licensee (if any), it is understood that the annual License Fee shall be $10,000, which shall be payable in full on the Commencement Date and each one-year anniversary thereof. With respect to each additional Feeder Fund covered by this Agreement pursuant to a separate written agreement between S&P and Licensee, the annual License Fee shall be the greater of $10,000 or one basis point (.0001) of the average daily net assets of such Feeder Fund, computed quarterly. The maximum annual License Fee for each such additional Feeder Fund shall be $250,000 plus the amount of increase (if any) in the CPI for Urban Consumers, All Items, as issued by the Bureau of Labor Statistics, U.S. Department of Labor, over the prior twelve month period. The parties agree that the terms upon which License Fees are calculated pursuant to this Exhibit B shall be considered “Confidential Informationfor purposes of Subsection 8(c) of this Agreement. Barclays Global Investors Mutual Fund Master/Feeder 500 Memorandum of Agreement dated this day of 200 , by and between , a corporation (the “Sublicensee”); Barclays Global Investors, N.A. (“Licensee”); and Standard & Poor’s a division of The XxXxxx-Xxxx Companies Inc., a N...
Product 2 consists of the Olink 48.48 IFC for Protein Expression, along with corresponding control line fluid required to use the chip. This particular IFC corresponds with SBI 48.48 Dynamic Array for Genotyping. Olink purchases the IFC and control line fluid using part number 102-1212 (Kit, Olink Bundle 2 - 48.48 IFC, 10-pack & CLF). “Product 3” consists of the Olink 24.192 IFC for Protein Expression, along with corresponding control line, actuation and pressure fluids required to use the chip. This particular IFC corresponds with SBI 192.24 Dynamic Array for Gene Expression. Olink purchases the IFC and IFC fluids using part number 102-1213 (Kit, Olink Bundle 3 - 24.192, 10-pack & CLF). This bundle includes the Pressure and Actuation Fluids as a separately packaged component (102-1210). While these fluids are needed to process the IFC, their formulations do not support further extension of expiration dating. Therefore, both reagents are excluded from the date extension scope of this study.
Product 2 means all steroid based products developed by the Company for the treatment of DME that possess at least the following characteristics: (a) contains a steroid as the primary active pharmaceutical ingredient; and (b) use a delivery technology (regardless of delivery duration) described in the Company’s invention disclosures and patent applications prepared and/or filed with the USPTO, prior to the Closing Date, a copy of which shall be delivered to Purchaser at or before the Closing (the “Product 2 Filings”).
Product 2 means all Product 2 products that also (a) contain Triamcinolone Acetonide as the primary active pharmaceutical ingredient; (b) have a duration of delivery of at least 5 months; and (c) deliver implants that are pre-loaded into a small gauge (25 gauge or smaller) needle.